Black Marble Capital Management

What Black Marble Capital Management does

Black Marble Capital Management Co., LTD (萬豐資本股份有限公司) is a privately held venture capital and investment management firm incorporated in Taiwan and headquartered in Zhongshan District, Taipei City. Founded in 2015, the firm structures venture capital investments and acts as a lead investor in private-equity-style deals, targeting early-stage and growth-stage opportunities within Taiwan's innovation ecosystem. Its portfolio spans biotechnology and medical technology (notably MPB Bio (巨生醫), Senhwa Biosciences (生華科), Taiwan Keto (台康生技), Formosa Pharmaceuticals (6838)), AI and cloud computing (CloudMile / 萬里雲), semiconductor display drivers (君曜, TDDI), and advanced manufacturing. The firm's stated differentiator is its access to Industrial Technology Research Institute (ITRI) spin-offs and Taiwan-based technology transfer opportunities, supplemented by repeat co-investment relationships with state-linked institutional partners such as 中華開發資本, 合作金庫創投, and the ITRI/資策會 Digital Economy Fund.

Name

Black Marble Capital Management

Legal name

Black Marble Capital Management Co., LTD

Website

https://blackmarble.com.tw

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Black Marble Capital Management (萬豐資本股份有限公司) is a privately held, Taipei-based venture capital firm founded in 2015 that structures investments and acts as lead investor in early- and growth-stage Taiwanese companies spanning biotechnology, medical technology, AI/cloud computing, and advanced manufacturing.

Ownership category

akta.pro rank

Product category

Venture Capital Management

NAICS

All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Late-Stage Venture Capital (Series C+) (FSANAAAC)

akta.pro secondary industry

Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

Keywords

• Venture capital management
• Private equity investing
• Biotech venture funding
• Growth stage investing
• Portfolio investment management

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Core offering

Black Marble Capital Management is a Taiwan-based venture capital and investment management firm that structures venture capital investments and private equity deals through the lead investor role. The firm deploys capital into early-stage and growth-stage Taiwanese companies across biotech, medical technology, AI/cloud computing, and advanced manufacturing, and supports portfolio companies with strategic guidance and industry network access.

Product overview

Black Marble Capital Management is a venture capital firm that provides investment management services. The company invests in portfolio companies across various sectors including biotechnology, cloud computing, and information technology. The firm does not offer a unified product platform but rather serves as a capital provider and investment advisor.

Differentiator

Problem solved

Functional benefit

Products and services

• Investment Management Services

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cherubic Ventures: Taiwan-anchored early-stage VC with portfolio across consumer tech, SaaS, and frontier tech. Comparable in Taiwan-centric orientation and early-stage positioning, though with a different sector tilt.
• Hotung Investment Holdings: Taiwan-listed VC firm investing in early- and growth-stage technology and biotech companies. Comparable in stage, sector mix, and Taiwan-centric orientation.
• Substance Capital: Cross-border VC that led CloudMile's Series B in which Black Marble participated. Comparable in Asia tech/cloud-AI thesis and stage focus, and operates as a co-investor in the same deals.
• Mega Ventures: Taiwan-based VC arm of Mega Financial Holding. Comparable as a domestic institutional VC investing across biotech and technology at multiple stages.
• Taiwania Capital: Taiwan-based, government-backed VC firm investing across biotech, ICT, and AI with both domestic and international reach. Comparable in mission, Taiwan focus, and cross-stage mandate.
• WI Harper Group: Cross-border VC firm with deep Taiwan roots investing in early-to-growth-stage tech and healthcare. Comparable in stage, sector overlap (especially healthcare), and US-Asia bridging function.
• ITIC (Industrial Technology Investment Corporation): Taiwan government-affiliated VC/PE firm closely tied to ITRI and technology transfer. Highly comparable as a Taiwan-focused investor in spin-outs and early-stage tech, and a co-investor in the same Formosa Pharma round.
• CDIB Capital Group: One of Taiwan's largest VC/PE platforms, a subsidiary of China Development Financial Holding. Directly comparable as a Taiwan-based, multi-stage investor across biotech and tech — and a co-investor alongside Black Marble in the Formosa Pharma Series C.

Regional players

• JAFCO Asia: Asia-headquartered VC arm of JAFCO Japan with Taiwan and Southeast Asia exposure. Comparable in stage focus and tech/biotech deal mix, though operating at larger scale and broader geography.

Broad incumbents

• National Development Fund (Taiwan, Executive Yuan): Taiwan's sovereign/co-investment venture platform administered by the Executive Yuan. Comparable as a key source of co-investment capital and policy-driven investor in Taiwan's tech and biotech ecosystem.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Black Marble Capital Management